High-throughput Kell, Kidd, and Duffy matrix-assisted laser desorption/ionization, time-of-flight mass spectrometry-based blood group genotyping of 4000 donors shows close to full concordance with serotyping and detects new alleles

Transfusion

Volumn 54, Issue 12, 2014, Pages 3198-3207

  Meyer, Stefan ^a   Vollmert, Caren ^b   Trost, Nadine ^a   Brönnimann, Chantal ^a   Gottschalk, Jochen ^a   Buser, Andreas ^c   Frey, Beat M ^a   Gassner, Christoph ^a  

^a Department of Molecular Diagnostics Andamp Research MOC   (Switzerland)

^b Sequenom GmbH Hamburg   (Germany)

^c Swiss Red Cross   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GENOMIC DNA; PRIMER DNA; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KIDD SYSTEM; CELL SURFACE RECEPTOR; DARC PROTEIN, HUMAN; KEL PROTEIN, HUMAN; MEMBRANE PROTEIN; METALLOPROTEINASE;

AFRICAN; ALLELE; ARTICLE; BLOOD DONOR; BLOOD GROUP; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP KIDD SYSTEM; BLOOD GROUP SYSTEM; BLOOD GROUP TYPING; BLOOD TRANSFUSION; CAUCASIAN; DATA BASE; GENE SILENCING; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PHENOTYPE; POLYMERASE CHAIN REACTION; SEROLOGY; SEROTYPING; SINGLE NUCLEOTIDE POLYMORPHISM; TECHNOLOGY; ADULT; CHEMISTRY; CLINICAL TRIAL; DEVICES; FEMALE; GENETICS; GENOTYPING TECHNIQUE; MALE; MASS SPECTROMETRY; MIDDLE AGED; NUCLEIC ACID DATABASE; PROCEDURES; SWITZERLAND;

ADULT; ALLELES; DATABASES, NUCLEIC ACID; DUFFY BLOOD-GROUP SYSTEM; FEMALE; GENOTYPING TECHNIQUES; HUMANS; KIDD BLOOD-GROUP SYSTEM; MALE; MEMBRANE GLYCOPROTEINS; METALLOENDOPEPTIDASES; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SWITZERLAND;

EID: 84916604985     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12715     Document Type: Article

References (49)

1. Lee BK, Ploner A, Zhang Z, et al. Constructing a population-based research database from routine maternal screening records: a resource for studying alloimmunization in pregnant women. PloS One 2011; 6: e27619.
2. Klein HG, Anstee D,. Mollison's blood transfusion in clinical medicine. 11th ed. Oxford, UK: Wiley-Blackwell; 2005.
3. Geifman-Holtzman O, Wojtowycz M, Kosmas E, et al. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997; 89: 272-275.
4. Redman M, Regan F, Contreras M,. A prospective study of the incidence of red cell allo-immunisation following transfusion. Vox Sang 1996; 71: 216-220.
5. Heddle NM, Soutar RL, O'Hoski PL, et al. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol 1995; 91: 1000-1005.
6. Tormey CA, Fisk J, Stack G,. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion 2008; 48: 2069-2076.
7. Poole J, Daniels G,. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007; 21: 58-71.
8. Food and Drug Administration, Center for Biologics Evaluation and Research. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2011. 2011. [cited 2013 Dec 9]. Available from: http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm302847.htm
9. Anstee DJ,. Red cell genotyping and the future of pretransfusion testing. Blood 2009; 114: 248-256.
10. Daniels G,. The molecular genetics of blood group polymorphism. Hum Genet 2009; 126: 729-742.
11. Daniels G,. Human bood groups. 3rd ed. Oxford: Blackwell Science; 2013.
12. Flegel WA,. Molecular genetics and clinical applications for RH. Transfus Apher Sci 2011; 44: 81-91.
13. Reid ME,. MNS blood group system: a review. Immunohematology 2009; 25: 95-101.
14. Gassner C, Meyer S, Frey BM, et al. Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry-based blood group genotyping-The alternative approach. Transfus Med Rev 2013; 27: 2-9.
15. Hopp K, Weber K, Bellissimo D, et al. High-throughput red blood cell antigen genotyping using a nanofluidic real-time polymerase chain reaction platform. Transfusion 2010; 50: 40-46.
16. Stabentheiner S, Danzer M, Niklas N, et al. Overcoming methodical limits of standard RHD genotyping by next-generation sequencing. Vox Sang 2011; 100: 381-388.
17. Denomme GA, Johnson ST, Pietz BC,. Mass-scale red cell genotyping of blood donors. Transfus Apher Sci 2011; 44: 93-99.
18. Hashmi G, Shariff T, Seul M, et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005; 45: 680-688.
19. Avent ND, Martinez A, Flegel WA, et al. The Bloodgen Project of the European Union, 2003-2009. Transfus Med Hemother 2009; 36: 162-167.
20. Kormoczi GF, Wagner T, Jungbauer C, et al. Genetic diversity of KELnull and KELel: a nationwide Austrian survey. Transfusion 2007; 47: 703-714.
21. Gassner C, Doescher A, Drnovsek TD, et al. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion 2005; 45: 527-538.
22. Hardy GH,. Mendelian proportions in a mixed population. Science 1908; 28: 49-50.
23. Tusnady GE, Simon I,. The HMMTOP transmembrane topology prediction server. Bioinformatics 2001; 17: 849-850.
24. Kall L, Krogh A, Sonnhammer EL,. A combined transmembrane topology and signal peptide prediction method. J Mol Biol 2004; 338: 1027-1036.
25. Hirokawa T, Boon-Chieng S, Mitaku S,. SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 1998; 14: 378-379.
26. Hofmann K, Stoffel W,. TMBASE-a database of membrane spanning protein segments. Biol. Chem. Hoppe-Seyler 1993; 374: 1-6: 143-70.
27. von Heijne G,. Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. J Mol Biol 1992; 225: 487-494.
28. Ren J, Wen L, Gao X, et al. CSS-Palm 2.0: an updated software for palmitoylation sites prediction. Protein Eng Des Sel 2008; 21: 639-644.
29. Gupta R, Jung E, Brunak S,. NetNGlyc 1.0 Server. 2004. [cited 2013 Dec 9]. Available from: http://www.cbs.dtu.dk/services/NetNGlyc/
30. Julenius K, Molgaard A, Gupta R, et al. Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 2005; 15: 153-164.
31. Ferre F, Clote P,. DiANNA 1.1: an extension of the DiANNA web server for ternary cysteine classification. Nucleic Acids Res 2006; 34: W182-185.
32. Irshaid NM, Eicher NI, Hustinx H, et al. Novel alleles at the JK blood group locus explain the absence of the erythrocyte urea transporter in European families. Br J Haematol 2002; 116: 445-453.
33. Hult A, Hellberg A, Wester ES, et al. Blood group genotype analysis for the quality improvement of reagent test red blood cells. Vox Sang 2005; 88: 265-270.
34. Zimmerman PA, Woolley I, Masinde GL, et al. Emergence of FY∗A(null) in a Plasmodium vivax-endemic region of Papua New Guinea. Proc Natl Acad Sci U S A 1999; 96: 13973-13977.
35. National Center for Biotechnology Information. National Center for Biotechnology Information (NCBI). dbSNP, NCBI Build 138, Phase I 2013. [cited 2013 Dec 9]. Available from: http://www.ncbi.nlm.nih.gov/snp/
36. Zelinski T, Coghlan G, Liu XQ, et al. ABCG2 null alleles define the Jr(a-) blood group phenotype. Nat Genet 2012; 44: 131-132.
37. Storry JR, Joud M, Christophersen MK, et al. Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype. Nat Genet 2013; 45: 537-541.
38. Martin-Blanc S, Simon P, Gien D, et al. Identification of novel silent KEL alleles causing KEL:-5 (Ko) phenotype or discordance between KEL:1,-2 phenotype/KEL∗01/02 genotype. Transfusion 2013; 53 (11 Suppl 2): 2859-2866.
39. Giblett E,. Js, a new blood group antigen found in Negroes. Nature 1958; 181: 1221-1222.
40. Giblett E, Chase J,. Jsa, a "new" red-cell antigen found in Negroes: evidence for an eleventh blood group system. Br J Haematol 1959; 5: 319-326.
41. Velliquette RW, Hue-Roye K, Lomas-Francis C, et al. Molecular basis of two novel and related high-prevalence antigens in the Kell blood group system, KUCI and KANT, and their serologic and spatial association with K11 and KETI. Transfusion 2013; 53 (11 Suppl 2): 2872-2881.
42. Meny GM,. The Duffy blood group system: a review. Immunohematology 2010; 26: 51-56.
43. ISBT. Committee on Terminology for RBC Surface Antigens. 2012. [cited 2013 Dec 9]. Available from: http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology
44. Iwamoto S, Li J, Omi T, et al. Identification of a novel exon and spliced form of Duffy mRNA that is the predominant transcript in both erythroid and postcapillary venule endothelium. Blood 1996; 87: 378-385.
45. Gassner C, Kraus RL, Dovc T, et al. Fyx is associated with two missense point mutations in its gene and can be detected by PCR-SSP. Immunohematology 2000; 16: 61-67.
46. Kappler-Gratias S, Peyrard T, Beolet M, et al. Blood group genotyping by high-throughput DNA analysis applied to 356 reagent red blood cell samples. Transfusion 2011; 51: 36-42.
47. Veldhuisen B, van der Schoot CE, de Haas M,. Blood group genotyping: from patient to high-throughput donor screening. Vox Sang 2009; 97: 198-206.
48. Jungbauer C, Hobel CM, Schwartz DW, et al. High-throughput multiplex PCR genotyping for 35 red blood cell antigens in blood donors. Vox Sang 2012; 102: 234-242.
49. Haer-Wigman L, Ji Y, Loden M, et al. Comprehensive genotyping for 18 blood group systems using a multiplex ligation-dependent probe amplification assay shows a high degree of accuracy. Transfusion 2013; 53 (11 Suppl 2): 2899-2909.